Skip to main content
Daan Gene Co., Ltd. logo

Daan Gene Co., Ltd. — Investor Relations & Filings

Ticker · 002030 ISIN · CNE000001KP1 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,189 across all filing types
Latest filing 2025-10-30 Governance Information
Country CN China
Listing Shenzhen Stock Exchange 002030

About Daan Gene Co., Ltd.

https://www.daangene.com

Daan Gene Co., Ltd. specializes in the development and manufacturing of molecular diagnostic products and services. The company focuses on in vitro diagnostic technologies, particularly polymerase chain reaction (PCR) platforms. Its product portfolio includes diagnostic kits for infectious diseases, genetic screening, and oncology, alongside automated nucleic acid extraction systems and real-time PCR instruments. Daan Gene provides comprehensive solutions for clinical laboratories and public health institutions, integrating research, production, and clinical testing services. The organization emphasizes technological innovation in molecular biology to support precision medicine and disease control.

Recent filings

Filing Released Lang Actions
关联交易管理制度（2025年10月）
Governance Information Classification · 95% confidence The document is titled '关联交易管理制度' which translates to 'Related Party Transaction Management System'. It is a detailed internal policy document outlining the principles, definitions, procedures, pricing, approval, and disclosure requirements for related party transactions within the company. It references relevant laws and stock exchange rules, and includes governance and compliance measures. There is no indication that this is a financial report, audit report, earnings release, or any form of regulatory filing announcing financial results or changes. It is a governance-related internal control document focused on managing related party transactions. Therefore, it fits best under Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices. The document length (5881 characters) and content confirm it is a substantive governance policy, not a brief announcement or certification.
2025-10-30 Chinese
关于召开2025年第四次临时股东会的通知
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a detailed notice about convening the 2025 fourth extraordinary general meeting (临时股东会) of Guangzhou Da An Gene Co., Ltd. It includes information about the meeting time, location, agenda items (such as election of independent directors, amendments to company policies), voting procedures, and proxy authorization forms. The document does not contain financial statements or results, nor is it a transcript or presentation. It is a formal announcement to shareholders about the meeting and the proposals to be voted on. This fits the definition of a Proxy Solicitation & Information Statement (PSI), which provides materials sent to shareholders to inform and request votes for meetings. The document length (5663 characters) and content confirm it is the meeting notice and proxy materials, not just a brief announcement or a report publication announcement.
2025-10-30 Chinese
2025年三季度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled '2025 年第三季度报告' which translates to '2025 Third Quarter Report'. It contains detailed financial data including income, profit, cash flow, balance sheet items, and explanations of changes in financial metrics. The presence of quarterly financial data and analysis indicates this is a comprehensive interim financial report. The document length is 15,000 characters, which is substantial and contains actual financial statements and analysis, not just an announcement or certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR).
2025-10-30 Chinese
关于取得一个医疗器械注册证的提示性公告
Regulatory Filings Classification · 95% confidence The document is a short announcement (505 characters) about the company obtaining a medical device registration certificate from a regulatory authority. It does not contain financial data, management changes, or detailed report content. It is an official notice about a regulatory approval related to the company's product, which fits best under Regulatory Filings (RNS) as it is a general regulatory announcement that does not fit other specific categories.
2025-09-29 Chinese
关于取得一个医疗器械注册证的提示性公告
Regulatory Filings Classification · 95% confidence The document is a short announcement (646 characters) from Guangzhou Da An Gene Co., Ltd. about obtaining a medical device registration certificate issued by the National Medical Products Administration. It describes the product and its intended use, and includes a risk warning to investors. There is no financial data, no mention of financial results, no regulatory certifications or attestations, and no reference to shareholder meetings or voting. The document is an official company announcement about a regulatory approval related to product registration, which does not fit into financial report categories like Annual Report, Interim Report, or Earnings Release. It is not a report publication announcement since it contains substantive information rather than just a notice of report availability. The best fitting category is Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2025-09-26 Chinese
2025年第三次临时股东会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a detailed announcement of the resolutions passed at the 2025 third extraordinary shareholders meeting of Guangzhou Da An Gene Co., Ltd. It includes information about the meeting date, voting methods, attendance, voting results on various proposals including amendments to the company charter and internal rules, and legal opinions from lawyers confirming the legality of the meeting and resolutions. The document does not contain financial statements or performance data, nor is it a transcript or presentation. It is a formal announcement of shareholder meeting resolutions and voting outcomes, which fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is 3150 characters, which is consistent with an announcement rather than a full report. Therefore, the correct classification is DVA with high confidence.
2025-09-15 Chinese

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.